SIGNet’s functions are to:
- Link network Executive Officers
- Facilitate information sharing and mentoring of new Executive Officers
- Provide an opportunity to share insights on activities done well and to identify solutions to problems
- Provide updates from the sector and to receive updates from ACTA.
SIGNet is ACTA’s Special Interest Group for Network Managers. Each Clinical Trial Network may nominate a representative on SIGNet.
SIGNet provides a forum for Executive Officers, Network Managers and CTN representatives (generally referred to as Executive Officers), to share knowledge and expertise, identify issues, exchange information and engage in collaborative problem solving.
Latest Resources
ACTA activity work plan 2019 – 2020
ACTA Advisory Council minutes July 2017
ACTA Resources Brochure
ACTA STInG Submission to the NHMRC Structural Review
ACTA Submission on draft Principles for accessing and using publicly funded data for health research
ACTA submission on revised table of standard costs for clinical trials
ACTA submission on safety monitoring & reporting of clincial trials in Australia
ACTA Submission on the MRFF Strategy & Priorities
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft
ACTA Submission to Senate Inquiry into Australia’s Innovation System
ACTA Submission to the Community Affairs Legislation Committee on the Medical Research Future Fund Bill 2015
ACTA Submission to The Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Costing Study
ACTA Submission to the Medicare Benefits Schedule Review Taskforce
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
ACTA Submission to the NHMRC Statement on Consumer & Community Involvement in Health & Medical Research: Public Consultation
ACTA Submission to the NHMRC Structural Review
ACTA Submission to the Select Committee on Health
ACTA Summit 2016 – Dr Neil Soderlund
ACTA Summit 2016 – Opening address
ACTA welcomes Government commitment to get clinical trials back on track
Australian Clinical Trials Alliance welcomes Government commitment to get clinical trials back on track
Australian clinical trials networks shaping modern medicine: Local doctors recognised among the world’s most influential researchers of our time
Australian researchers pause with global counterparts to acknowledge vital role of clinical trials in saving lives and advancing medicine
Australian researchers pause with global counterparts to acknowledge vital role of clinical trials in saving lives and advancing medicine
Clinical effectiveness research: a critical need for health sector research governance capacity. MJA 2013
Economic evaluation of investigator-initiated clinical trials conducted by networks
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
First communique from the newly-formed Clinical Trials Advisory Committee (CTAC)
Forming networks for research: Proposal for an Australian Clinical Trials Alliance. MJA 2013
General practice-based clinical trials MJA 2013
How can clinical trials networks drive better translation of evidence into better quality care?
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials
Report on the ACTA 2014 National Summit of Clinical Trials Networks
Latest News
ACTA Annual General Meeting and Advisory Council Meeting
ACTA celebrates successful International Clinical Trials Conference
ACTA Member finds prostate cancer pill gives patients 30% better survival rate
ACTA website survey
All.Can cancer survey highlights patient experience
Call for new Members for ACTA’s Reference Groups
Conference speaker and Executive Director of CTTI releases recommendations for mobile technology trials
Federal Minister for Health opening ACTA International Clinical Trials Conference
Gala Dinner at Doltone House
Gold Walkley recipient, Dr Norman Swan, confirmed as a speaker at ACTA Conference Gala Dinner
Health Economics 101 – designing cost-effectiveness studies alongside trials
International leaders in Clinical Trials meet in Sydney
New ACTA Resources Brochure
Pre-Conference workshops
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions